ARC Group Participates in Shenzhen Enterprise Brand Globalization Service Day

ARC Group Participates in Shenzhen Enterprise Brand Globalization Service Day

ARC Group participated in the “Enterprise Brand Globalization Service Day” in Longgang District, Shenzhen. The event, themed “Sailing Global, Charted with Quality,” convened more than 150 representatives from international business organizations across Thailand, Malaysia, Singapore, and Italy, alongside leading industry associations and enterprises spanning new energy, medical devices, smart terminals, and advanced manufacturing.

Xi Zhang, Partner at ARC Group, delivered a presentation on strategies for companies going global through compliance management frameworks, with a focus on Southeast Asia case studies. He emphasized the importance of regulatory alignment, risk management, and practical lessons learned from regional markets.

Xi Zhang, Partner at ARC Group, at Shenzhen Enterprise Brand Globalization Service Day

Alicia Tien, Manager – Corporate Access at ARC Group, shared perspectives on investment strategies and key opportunities for Chinese enterprises in Malaysia, highlighting how companies can leverage regional market dynamics to expand internationally.

Alicia Tien, Manager – Corporate Access at ARC Group, at Shenzhen Enterprise Brand Globalization Service Day

The event, co-hosted by the Shenzhen Municipal Market Supervision Bureau and Longgang District, also marked the unveiling of the Brand International Communication Shenzhen Center under the China International Communications Group (CICG), further building a national-level platform to support SMEs in their globalization journey.

ARC Group remains committed to supporting Chinese enterprises in navigating international markets through strategic advisory, compliance guidance, and capital markets expertise.

Shenzhen Enterprise Brand Globalization Service Day

Shenzhen Enterprise Brand Globalization Service Day

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission